Max Robotics — Global Service Robot Directory + US Certification

About

Carl Koschmann is a leading researcher in pediatric neuro-oncology, with a primary focus on diffuse intrinsic pontine glioma (DIPG), a devastating and almost universally fatal childhood brain tumor. His work has significantly advanced both the understanding and treatment of this disease. Koschmann has been at the forefront of developing and evaluating experimental therapies for DIPG, contributing to critical updates in diagnostic techniques and treatment strategies. A key innovation in his research is the development of automated microinjection for zebrafish xenograft models, a technique that dramatically improves the precision and throughput of cancer cell injection into larvae. This breakthrough has enhanced the utility of zebrafish as a predictive tool for patient responses to cancer therapeutics, moving these models closer to clinical diagnostic use. With his most-cited papers already accumulating over 10 citations, Koschmann’s work is recognized for bridging cutting-edge laboratory methods with urgent clinical needs, offering new hope for improving outcomes in pediatric brain cancer.